VIPASANA 100 Tablet is a high-strength pharmaceutical formulation containing Sertraline Hydrochloride 100 mg, classified under the selective serotonin reuptake inhibitor (SSRI) category. This medicine is primarily prescribed for the treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), panic disorder, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and premenstrual dysphoric disorder (PMDD). By increasing serotonin levels in the brain, VIPASANA 100 helps enhance emotional regulation, reduce depressive symptoms, alleviate anxiety, and bring about a sense of emotional balance and mental clarity.

This medication works by blocking the reabsorption (reuptake) of serotonin in the brain, making more of this neurotransmitter available for improving communication between nerve cells. Over time, this elevation of serotonin levels can lead to better mood, reduced anxiety, and improved mental well-being. VIPASANA 100 is generally administered once daily, preferably at the same time each day, with or without food, depending on the physician’s advice. It may take a few weeks to achieve noticeable therapeutic effects, and patients are advised to maintain consistent usage without abruptly discontinuing the medication unless advised by a healthcare provider.

VIPASANA 100 is manufactured under stringent quality standards in WHO-GMP-certified facilities to ensure compliance with international safety and efficacy regulations. Every batch undergoes rigorous quality control checks to ensure product stability, purity, and therapeutic accuracy. The tablet is engineered for optimal bioavailability, ensuring consistent release and absorption in the gastrointestinal tract for sustained action throughout the day. Its robust formulation makes it suitable for third-party manufacturing, contract manufacturing, and export to regulated and semi-regulated pharmaceutical markets under private labeling agreements.

Patients prescribed VIPASANA 100 may experience mild to moderate side effects including nausea, insomnia, dizziness, dry mouth, increased sweating, or gastrointestinal disturbances. These effects are often transient and typically diminish as the body adjusts to the medication. However, patients should report any unusual mood changes, suicidal thoughts, or serotonin-related symptoms such as agitation or confusion, particularly at the beginning of treatment or after dose adjustments. The medication should be used cautiously in patients with liver impairment, seizure disorders, bipolar disorder, or a history of substance abuse.

VIPASANA 100 is contraindicated in combination with monoamine oxidase inhibitors (MAOIs) and should not be taken within 14 days of discontinuing such agents due to the risk of serotonin syndrome. Alcohol consumption should be minimized during treatment to avoid worsening side effects such as drowsiness or cognitive impairment. Pregnant and lactating women should only take this medicine if the benefits outweigh the risks, and under medical supervision.